Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy-Reference-Cited by-同舟云学术

Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy

Published:2012-01-08 Issue:1 Volume:7 Page:188-198
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Hsu Chia-Yang,Lee Yun-Hsuan,Huang Yi-Hsiang,Hsia Cheng-Yuan,Su Chien-Wei,Lin Han-Chieh,Lee Rheun-Chuan,Chiou Yi-You,Lee Fa-Yauh,Huo Teh-Ia,Lee Shou-Dong

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-011-9338-z.pdf

Reference39 articles.

1. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439–474

2. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817–823

3. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529–538

4. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006;55(Suppl 6):vi1–vi12

5. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361:1279–1290

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab;Digestive and Liver Disease;2024-09

2. Phase Angle but Not Psoas Muscle Predicts Nutritional Risk and Prognosis in Males with Hepatocellular Carcinoma;Nutrition and Cancer;2024-07-16

3. Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study;Journal of Hepatocellular Carcinoma;2024-07

4. Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi Arabia;Cureus;2024-01-20

5. Intraperitoneal PD-1 monoclonal antibody for the treatment of advanced primary liver cancer with malignant ascites: a single-arm, single-center, phase Ib trial;ESMO Open;2024-01